A design for phase I trials in completely or partially ordered groups-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A design for phase I trials in completely or partially ordered groups

Published:2017-04-06 Issue:15 Volume:36 Page:2323-2332
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Conaway Mark R.¹^ORCID

Affiliation:

1. Department of Public Health Sciences; University of Virginia Health System; P.O. Box 800717 Charlottesville 22908 VA U.S.A.

Funder

National Cancer Institute of the National Institutes of Health

National Institutes of Health

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference30 articles.

1. Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the national cancer institute organ dysfunction working group;Ramanathan;Journal of Clinical Oncology,2008

2. Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432;LoRusso;Clinical Cancer Research,2012

3. Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study;Leal;Cancer Chemotherapy and Pharmacology,2011

4. A UGT1A1*28 and *6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer;Kim;Cancer Chemotherapy and Pharmacology,2013

5. Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1*28 and or UGT1A1*6 polymorphisms;Satoh;Cancer Science,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A model‐assisted design for partially or completely ordered groups;Pharmaceutical Statistics;2024-05-20

2. Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses;Clinical Trials;2024-01-19

3. The quasi-CRM shift method for partially ordered groups;Contemporary Clinical Trials;2024-01

4. Isotonic Phase I Cancer Clinical Trial Design Utilizing Patient-Reported Outcomes;Statistics in Biopharmaceutical Research;2023-11-28

5. Isotonic design for phase I cancer clinical trials with late-onset toxicities;Journal of Biopharmaceutical Statistics;2023-01-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3